EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

HK2 / VDAC1 Axis Regulates Malignant Progression of Esophageal Squamous Cell Carcinoma

Chenlu Dai iD, Jingyu Liu, Yaling Guan, Sensen Zhu, Mengjie Zhuang, Li Liu, Min Ji, Xuanming Liu, Ming Cheng, Linlin Zhang, Yan Ma, Liping Su und 1 weitere

Cancer Medicine · 2026-07 · 15 (7)

DOI: 10.1002/cam4.72102 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cancer Medicine, online erschienen am 12.07.2026. Verfasst von Chenlu Dai und 12 weiteren Autor:innen. Beteiligte Einrichtung: School of Basic Medicine, Xinjiang Medical University, Urumqi, China. Hauptthemen laut MEDLINE: Voltage-Dependent Anion Channel 1, Esophageal Squamous Cell Carcinoma, Esophageal Neoplasms, Hexokinase. Die Arbeit nennt 32 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: State Key Laboratory of Pathogenesis, Prevention and Treatemt of High Incidence Diseases in Central Asia.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Esophageal squamous cell carcinoma (ESCC) remains a lethal malignancy with limited effective therapies. Although hexokinase 2 (HK2) is upregulated in multiple cancers, its role in ESCC progression and underlying mechanisms, particularly its interaction with the mitochondrial damage pathway, remains incompletely understood.

Methods

Bioinformatic analyses and clinical specimens were used to evaluate HK2 expression in ESCC and its association with prognosis. Functional assays, including CCK‐8, wound healing, Transwell, flow cytometry, ROS detection, JC‐1 staining, and mitochondrial protein analyses, were performed in ESCC cells with HK2 overexpression or knockdown. Co‐immunoprecipitation (CO‐IP) was conducted to validate the physical interaction between HK2 and VDAC1. A subcutaneous xenograft model was used to assess the pro‐tumorigenic role of HK2 in vivo.

Results

HK2 was markedly overexpressed in ESCC and was associated with poor prognosis. Mechanistically, HK2 interacted with VDAC1 on the outer mitochondrial membrane, suppressed mitochondrial depolarization and ROS accumulation, protected mitochondrial function, and thereby promoted ESCC cell proliferation, migration, and invasion. Conversely, HK2 knockdown disrupted HK2–VDAC1‐associated mitochondrial regulation, induced mitochondrial dysfunction and apoptosis, and attenuated malignant phenotypes. In vivo, HK2 overexpression promoted tumor growth, whereas HK2 knockdown significantly suppressed tumor progression.

Conclusion

These findings suggest that HK2 promotes ESCC progression at least partly by interacting with VDAC1, protecting mitochondrial function and reducing cell apoptosis. The HK2–VDAC1 axis may represent a potential therapeutic vulnerability in ESCC.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Voltage-Dependent Anion Channel 1Esophageal Squamous Cell CarcinomaEsophageal NeoplasmsHexokinaseHumansAnimalsDisease ProgressionCell Line, TumorMiceCell ProliferationApoptosisPrognosisMitochondriaCell MovementMaleGene Expression Regulation, NeoplasticReactive Oxygen SpeciesFemaleMice, Nude

Stichwörter der Autor:innen

HK2VDAC1apoptosisesophageal squamous cell carcinomatumor progression

Substanzen

Voltage-Dependent Anion Channel 1VDAC1 protein, humanHexokinaseHK2 protein, humanReactive Oxygen Species

Autor:innen und Institutionen

  • School of Basic Medicine, Xinjiang Medical University, Urumqi, China.
  • Department of Pathology, First Affliated Hospital, Xinjiang Medical University, Urumqi, China.
  • Orthopaedics and Traumatology, Urumqi Chinese Medicine Hospital, Urumqi, China.
  • State Key Laboratory of Pathogenesis, Prevention and Treatemt of High Incidence Diseases in Central Asia, Xinjiang Medical University, Urumqi, China.
  • Department of Discipline Construction, First Affliated Hospital, Xinjiang Medical University, Urumqi, China.
  • Key Laboratory of Forensic Medicine, Xinjiang Medical University, Urumqi, China.

ORCID-Profile: Chenlu Dai

Förderung

  • State Key Laboratory of Pathogenesis, Prevention and Treatemt of High Incidence Diseases in Central Asia

Zitieren

APA

Dai, C., Liu, J., Guan, Y., Zhu, S., Zhuang, M., Liu, L., Ji, M., Liu, X., Cheng, M., Zhang, L., Ma, Y., Su, L., & Pu, H. (2026). HK2 / VDAC1 Axis Regulates Malignant Progression of Esophageal Squamous Cell Carcinoma. Cancer Medicine, 15(7). https://doi.org/10.1002/cam4.72102

Vancouver

Dai C, Liu J, Guan Y, Zhu S, Zhuang M, Liu L, et al. HK2 / VDAC1 Axis Regulates Malignant Progression of Esophageal Squamous Cell Carcinoma. Cancer Medicine. 2026;15(7). doi:10.1002/cam4.72102

BibTeX
@article{Dai2026,
  author = {Dai, Chenlu and Liu, Jingyu and Guan, Yaling and Zhu, Sensen and Zhuang, Mengjie and Liu, Li and Ji, Min and Liu, Xuanming and Cheng, Ming and Zhang, Linlin and Ma, Yan and Su, Liping and Pu, Hongwei},
  title = {HK2 / VDAC1 Axis Regulates Malignant Progression of Esophageal Squamous Cell Carcinoma},
  journal = {Cancer Medicine},
  year = {2026},
  volume = {15},
  number = {7},
  doi = {10.1002/cam4.72102}
}
Kostenlos starten →